ArticleCancer research2019

Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.

Shilpa Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.